Hydrochlorothiazide (HCTZ) is used to manage hypertension and heart failure; however, its side effects include mild hypokalemia, metabolic abnormalities, and volume depletion, which might have deleterious effects on renal and endothelial function. We studied whether HCTZ cause renal injury and/or altered vasoreactivity and if these changes are hypokalemia-dependent. Rats were given a normal diet or a diet moderately low in potassium (K þ ) with or without HCTZ.
Hydrochlorothiazide (HCTZ) is used to manage hypertension and heart failure; however, its side effects include mild hypokalemia, metabolic abnormalities, and volume depletion, which might have deleterious effects on renal and endothelial function. We studied whether HCTZ cause renal injury and/or altered vasoreactivity and if these changes are hypokalemia-dependent. Rats were given a normal diet or a diet moderately low in potassium (K þ ) with or without HCTZ.
Animals fed either a low K þ diet alone or HCTZ developed mild hypokalemia. There was no significant difference in systolic blood pressure in the different treatment groups. All three groups with hypokalemia had mild proteinuria; low K þ -HCTZ rats had reduced creatinine clearance.
HCTZ-treated rats displayed hypomagnesemia, hypertriglyceridemia, hyperglycemia, insulin resistance, and hyperaldosteronism. No renal injury was observed in the groups without HCTZ; however, increased kidney weight, glomerular ischemia, medullary injury, and cortical oxidative stress were seen with HCTZ treatment. Endotheliumdependent vasorelaxation was reduced in all hypokalemic groups and correlated with reduced serum K þ , serum, and urine nitric oxide. Our results show that HCTZ is associated with greater renal injury for the same degree of hypokalemia as the low K þ diet, suggesting that factors such as chronic ischemia and hyperaldosteronism due to volume depletion may be responsible agents. We also found impaired endothelium-dependent vasorelaxation was linked to mild hypokalemia. Hydrochlorothiazide (HCTZ) and other thiazide diuretics reduce morbidity and mortality in hypertensive subjects by reducing the frequency of stroke and congestive heart failure. [1] [2] [3] However, thiazides do not protect against myocardial infarction relative to that expected for the degree of decrease in blood pressure 1, 4 and thiazides may also not protect against progressive renal disease. [5] [6] [7] Some studies suggest HCTZ use may actually increase the risk for renal progression in subjects with essential hypertension. 7 Indeed, HCTZ exacerbates renal injury in the spontaneously hypertensive rat. 8, 9 One potential mechanism by which thiazides might cause renal injury is via the induction of hypokalemia. Hypokalemia is a common clinical condition and occurs in 6.5-50% of patients receiving diuretics. [10] [11] [12] The relationship between hypokalemia and thiazides is dose-dependent, with the average reduction of serum potassium around 0.3-1.1 mEq l
À1
. [13] [14] [15] Studies in animals placed on severe potassium restricted diets have shown the development of hypokalemic nephropathy characterized by renal hypertrophy, renal tubular cell hyperplasia, tubular dilatation, interstitial cell infiltration, and fibrosis that is greatest in the outer medulla. This injury is mediated by both intrarenal complement activation 16 and intrarenal vasoconstriction secondary to an increase in vasoconstrictors (endothelin and angiotensin II) and a loss of vasodilators (nitric oxide (NO), prostaglandins, and kallikrein). 17 Increased vasoconstriction with oxidative stress was also observed in the carotid artery of animals fed a low K þ diet (LK). 18 In addition to hypokalemia, HCTZ may induce hypomagnesemia, hyperuricemia, hyperlipidemia, and impaired glucose metabolism 6, [19] [20] [21] [22] that could also contribute to renal injury and endothelial dysfunction. This has raised concern that HCTZ may be a double-sided sword with both beneficial and negative effects.
To date no study has attempted to distinguish the renal effects of thiazides from those induced by mild hypokalemia. Furthermore, to our knowledge, all previous studies examining the effect of potassium restriction on renal function and structure have utilized near complete potassium restriction, which is not physiologic. Hence, we determined if thiazide usage can induce renal injury and alter vasoreactivity and compared this with equivalent hypokalemia induced by moderate potassium restriction.
RESULTS

Serum K
þ , body weight, and urine volume
Rats fed on either a LK diet and/or HCTZ developed mild hypokalemia. Serum K þ fell by 10-15% within the first 2 weeks and reached 70-80% of control (normal K þ diet (NK)) levels by week 20 (Table 1) . Serum K þ was lowest in the LK þ HCTZ group but was similar in the LK and NK þ HCTZ groups (Table 1 and Figure 1a ). Hypokalemia was accompanied by increased serum bicarbonate (Table 1) .
Body weight (BW) was lower in both the LK and LK þ HCTZ groups at week 2 (Table 1) , but at killing, BW was only lower in the LK þ HCTZ group compared with the others (Table 1 and Figure 1b) . Nevertheless, the correlation between BW and serum K þ at week 20 was significant (r ¼ 0.49, P ¼ 0.025).
Urine volumes were increased significantly in both groups given HCTZ for the first 2 weeks but then were similar to the NK group (Figure 1c) . The LK þ HCTZ group had greater urine volume compared with the HCTZ group at day 3 (P ¼ 0.03). LK rats also had a tendency toward higher urine output during the first 2 weeks, although it was not significant (P ¼ 0.069 at day 3 and 0.057 at day 7 compared with the NK group).
The metabolic effects of HCTZ, serum insulin, and insulin resistance Consistent with reports in humans, both HCTZ-treated groups developed hypomagnesemia and hyperglycemia at weeks 4 and 15 ( Table 2) . Serum glucose negatively correlated with serum K þ (r ¼ À0.44, P ¼ 0.044). Also, serum triglycerides were higher in NK þ HCTZ and LK þ HCTZ rats compared with the NK and LK rats at week 20, although this did not reach significance in the latter (Po0.05 and 0.07, respectively). Serum uric acid and cholesterol were not different among groups. A tendency for higher hemoglobin was observed in rats receiving thiazides (P ¼ 0.07 vs NK group and P ¼ 0.05 vs LK group). Serum insulin. Serum insulin in rats receiving an LK had a tendency to be lower compared with rats receiving an NK (NK 256071010 vs LK 21647870, and NK þ HCTZ 34097 949 vs LK þ HCTZ 23247762 pg ml
À1
, P ¼ 0.076). Although the LK and NK þ HCTZ groups had similar serum K þ levels, serum insulin of the NK þ HCTZ rats was significantly higher ( Table 2) .
Quantitative insulin sensitivity check index. HCTZ-treated rats demonstrated insulin resistance compared with non-HCTZ receiving rats (NK vs NK þ HCTZ, P ¼ 0.031 and LK vs LK þ HCTZ, P ¼ 0.079 and LK vs NK þ HCTZ, P ¼ 0.002, Table 2 ).
Serum aldosterone
Compared with NK rats (270.5746.8 pg ml À1 ), NK þ HCTZ rats had higher serum aldosterone levels (4437182.1 pg ml À1 , Po0.05, Table 2 ). LK rats had lower serum aldosterone levels (165.4735.9 pg ml À1 ) compared with NK rats (Po0.01).
The muscular K þ content of LK, NK þ HCTZ, and LK þ HCTZ rats were significantly lower compared with NK rats, whereas the muscular Mg þ þ content adjusted for muscular protein was lower in HCTZ-treated rats (Table 3) . All groups had similar Na þ content. There was significant correlation between muscular K þ and Mg þ þ (r ¼ 0.78, Po0.001).
Renal injury
Kidney weight adjusted for BW. Although absolute kidney weights were not different, the kidney weight to body weight (KW/BW) ratio was significantly increased in both the NK þ HCTZ and LK þ HCTZ groups when compared with NK and LK rats (Table 1) .
Renal function. Serum blood urea nitrogen, creatinine, creatinine clearance, and urinary protein excretion are shown in Table 1 . All three groups with hypokalemia (LK, NK þ HCTZ, and LK þ HCTZ rats) had increased protein excretion compared with NK rats. A tendency for higher serum creatinine was observed in the NK+HCTZ rats (P ¼ 0.057 vs NK rats). Creatinine clearance was depressed in the LK þ HCTZ group compared with the NK group and tended to be lower in the NK þ HCTZ group.
Renal histology and immunohistochemistry. Neither glomerular hypertrophy (measured as total glomerular tuft area) nor mesangial matrix area was different between the four groups. No global or segmental glomerulosclerosis was observed in any group. There was no significant structural renal damage in NK and LK rats, whereas focal glomerular injury-characterized by wrinkling and thickening of the glomerular basement membrane, splitting of the Bowman capsule, glomerular collapse, and periglomerular fibrosis ( Figure 2 )-was revealed in both HCTZ-treated groups. This pattern of glomerular change suggested glomerular ischemia 23 or early changes of glomerular atrophy. Additionally, renal tubulointerstitial injury, such as tubular dilatation, cast formation, and interstitial cell infiltration, was also present in both HCTZ-treated groups. Although the renal injury induced by thiazides was subtle (less than 10% of area), it was significant when compared with that of the NK and LK groups (Table 4 and Figure 3a-d) . Injury to the medulla was also observed in rats receiving HCTZ, despite the fact that the LK group had similar potassium levels as the NK þ HCTZ group. The LK þ HCTZ group had more extensive renal damage than the other groups.
Osteopontin expression was increased significantly in LK þ HCTZ rats within the outer stripe of outer medulla and within the inner stripe of outer medulla (ISOM) of both NK þ HCTZ and LK þ HCTZ groups (Table 4 and Figure  4a-d) . Similarly, an increase in interstitial macrophage infiltration in the outer medulla was observed in both NK þ HCTZ and LK þ HCTZ groups (Table 4) .
Renal tubular cell proliferation of collecting ducts and medullary thick ascending limb (mTAL) was demonstrated by positive proliferative cell nuclear antigen (PCNA) staining, which was significantly higher in both NK þ HCTZ and LK þ HCTZ groups compared with NK and LK groups (Table 4 and Figure 5a-d) .
Renal oxidative stress
We investigated 8-isoprostaglandin F2 alpha and intracellular reduced glutathione as markers of oxidative stress (Table 5) . Cortical 8-isoprostaglandin F2 alpha was higher in both groups receiving HCTZ. Intracellular reduced glutathione was decreased in the LK þ HCTZ group. Additionally, intracellular reduced glutathione correlated positively with renal NO within both cortex (r ¼ 0.49, P ¼ 0.025) and medulla (r ¼ 0.46, P ¼ 0.038).
Endothelium-dependent vasorelaxation and NO
The percent relaxation of aortic rings in response to acetylcholine was reduced in all three hypokalemic groups compared with NK controls (Figure 6a ). All three hypokalemic groups also had significantly lower serum nitrite, urine nitrate and nitrite levels ( Table 6 ). Renal nitrate and nitrite levels were lower in the cortex but not in the medulla in the hypokalemic groups (Table 6 ). The decrease in serum nitrites correlated with the degree of hypokalemia and with the degree of impaired vasorelaxation of the aortic rings (Table 7 and Figure 6b ).
Systolic blood pressure
Blood pressure was not measured in the original cohort. However, another set of animals was treated identically and systolic blood pressure was measured at week 6. Tail cuff blood pressures of the NK, LK, NK þ HCTZ, and LK þ HCTZ groups were 13274.7, 13177.9, 12873.5, and 12678.5 mm Hg, respectively (P ¼ NS).
DISCUSSION
We compared the effects of mild hypokalemia induced by diet with mild hypokalemia induced by the diuretic thiazide on renal structure and function. The reason for this study was three-fold. First, our group and others have previously shown that marked potassium restriction (typical diets of 0.01% K) can induce substantial renal injury (hypokalemic nephropathy), but it remains unknown if milder dietary potassium restriction can induce renal damage. Second, the most common form of hypokalemia observed clinically is with diuretic use, and this observation, coupled with reports that thiazide diuretics might induce renal injury by themselves, raised the question of whether thiazides would induce similar or worse renal damage for the same degree of hypokalemia. Finally, the most important reason to perform these studies is that both diuretic usage and mild hypokalemia are common in clinical practice and it is important to determine if these processes can result in renal damage and whether they are additive. Rats on a moderate LK diet with or without HCTZ developed mild reduction (20-30%) of serum K þ levels. Importantly, hypokalemia was mild (3.2-3.6 mEq l
À1
) and similar to that observed commonly in patients. Furthermore, the degree of hypokalemia was similar in rats receiving HCTZ and a NK diet compared to rats treated with LK diet alone. This allowed us to evaluate whether HCTZ has effects on renal structure independent of hypokalemia.
Several features were common among the three groups that developed hypokalemia. Notably, all three groups developed endothelial dysfunction with impaired acetylcholine-dependent vasodilation (Figure 6a) , and with reduced serum, urinary, and renal nitrate/nitrites. These features correlated with serum K þ levels, which suggests that the hypokalemia may have a role in these changes. Interestingly, medullary NO levels were not altered, likely because the medulla is a major site for neuronal NO synthase and inducible NO synthase expression. [24] [25] [26] [27] [28] All three groups also developed mild proteinuria. Endothelial dysfunction is known to be induced by hypokalemia, 18 and both endothelial dysfunction and proteinuria are known to be risk factors for cardiovascular disease. These studies suggest that hypokalemia induced either by diet or thiazides could have long-term negative cardiovascular effects.
Most interestingly, however, was the differential effect of thiazides vs mild hypokalemia on renal structure. Thiazidetreated rats with mild hypokalemia had subtle renal injury that was not observed in the rats with diet induced mild hypokalemia. This injury was characterized by focal glomerular damage, which suggested glomerular ischemia or early changes of glomerular atrophy, and was accompanied by tubular injury primarily in the outer medullary area, characterized by tubular osteopontin expression, tubular cell proliferation, and increased macrophage infiltration. This was accompanied by increased cortical oxidative stress and by increased kidney weight adjusted for BW. Furthermore, these changes were exacerbated when rats were placed on both a LK diet and HCTZ.
There are several potential mechanisms to explain why thiazides may cause renal injury greater than one would expect for the level of hypokalemia. First, thiazides can induce mild volume depletion, as suggested by the higher hemoglobin and blood urea nitrogen values. The glomerular injury also suggests the presence of chronic ischemia. The observation that blood pressure was only slightly reduced rules out hypotension as a cause and suggests that the ischemic changes might be the result of impaired renal autoregulation. One possibility is the combined effects of volume depletion with arteriolar vasoconstriction from reduced cortical NO and increased cortical oxidative stress, 8-isoprostaglandin F2 alpha, which is a potent preglomerular vasoconstrictor. 29 Consistent with the present observations, previous studies involving spontaneously hypertensive rats treated with HCTZ and NO blockade showed evidence of glomerular injury and proteinuria. 9 In addition, treatment with a loop diuretic, furosemide, also reduced renal blood flow and increased renal vascular resistance. 30 Volume depletion from HCTZ may cause secondary hyperaldosteronism as shown in previous studies 31, 32 and in this study. Aldosterone may cause proteinuria and renal injury, [33] [34] [35] and aldosterone blockade can ameliorate renal injury in various experimental models. [36] [37] [38] Aldosterone acts in part by increasing plasminogen activator inhibitor-1 expression, 39 which is increased in rats receiving HCTZ. 40 HCTZ-treated rats also developed hyperglycemia, hypertriglyceridemia, and insulin resistance, which could potentially cause or accelerate renal injury. Chronic hyperglycemia can induce glomerular hypertrophy and mesangial matrix expansion, 41 ,42 but these were not observed in our rats exposed to HCTZ. Therefore, the renal injury in the HCTZ groups is likely not from hyperglycemia per se.
Thiazide use is also associated with the development of hyperuricemia, which has been strongly linked with renal hypertrophy, arteriolar vasoconstriction, and renal injury. 43 However, we could not demonstrate differences in uric acid levels in our groups. Uric acid levels can fluctuate during the day, and it remains possible that levels could be different if measured at other times (such as after drinking).
Urine volume of the HCTZ-treated rats was significantly increased during the first 2 weeks. It has previously been shown in humans that there is an association between higher urine volume and faster decline in GFR. 44 Ultimately, the urine volume decline to baseline level might be explained by the development of diuretic resistance. This resistance may be caused by a decrease of renal blood flow and renal function. 45 In conclusion, mild hypokalemia such as commonly observed in clinical practice may be associated with endothelial dysfunction and mild proteinuria, but we could not document significant renal structural changes up to 20 weeks. In contrast, thiazides were associated not only with hypokalemia, but also with hypomagnesemia, hyperlipidemia, impaired glucose metabolism, insulin resistance, and aldosterone stimulation. Our study demonstrates another side effect: the induction of mild renal injury that is greater than expected for the degree of hypokalemia. Whether similar concerns exist for loop diuretics that can also induce similar metabolic abnormalities 46 remains to be explored. Importantly, diuretics may not be necessary in many patients with chronic kidney disease. For example, in the Modification of Diet in Renal Disease study and in the African American Study of Kidney Disease and Hypertension trial, about half of the patients achieved their blood pressure goals without requirement of diuretic therapy. 47 Further studies are underway to determine the mechanism(s) by which thiazides induce renal injury independent of potassium. Although diuretic use can be life saving, physicians should monitor the potential negative metabolic effects of thiazides and correct them when they occur.
MATERIALS AND METHODS
All animal studies were approved by the University of Florida Institutional Animal Use and Care Committee (IACUC). Experimental study Male Sprague-Dawley rats (150-175 g, Charles River, Wilmington, MA, USA) were placed on a NK (0.36%K þ , 0.1%Na þ , Harlan, Madison, WI, USA) for a 5-day run-in period and were divided into four groups (n ¼ 5-6 per group).
Pilot study
dissolved in drinking water Group 4 (LK þ HCTZ): low K þ diet plus the same dose of HCTZ Rats were weighed weekly and urine was collected over 18 h at days 1, 3, 7, 14, and weeks 3, 4, 6, 10, 15, and 20. Serum was collected at weeks 2, 4, 10, 15, and 20. Rats were killed at week 20. Excised aortic artery (AA) segments (n ¼ 3 per group) were used to evaluate endothelium-dependent vasorelaxation. The cortex and medulla of the right kidney was separated and frozen at À801C for later analysis for nitrites and oxidative stress markers. The other kidney was divided into cross-sectional pieces and fixed in Methyl Carnoys, 10% formalin, and periodate lysine paraformaldehyde fixative for histologic studies. Soleus muscle (40-80 mg) was obtained for intracellular measurement of K þ , Na þ , and Mg þ þ . In the original protocol, blood pressure measurements were not determined (other than in the pilot study noted above). We therefore repeated the experiment using the same age and size Sprague-Dawley rats with the same diets and dose of HCTZ (NK, NK þ HCTZ, LK, LK þ HCTZ, n ¼ 6 per group) and measured systolic blood pressure by tail cuff sphygmomanometer (Visitech BP2000, Visitech Systems, Apex, NC, USA) at week 6 as described previously. 50 Biochemical measurements Serum and urine K þ were determined by atomic absorption spectrophotometer (Perkin-Elmer 306, Downers arove, IL, USA). Blood chemistries were measured by an autoanalyzer (Alfa Wassermann, West Caldwell, NJ, USA). Urinary protein was measured with the protein kit (Bio-Rad, Hercules, CA, USA). A complete blood count was done using the hematology analyzer (Drew Scientific, Oxford, CT, USA).
Serum insulin and the quantitative insulin sensitivity check index
Fasting serum glucose and insulin were obtained at the week 15. Serum insulin was determined by an enzyme-linked immunosorbent assay kit (Crystal Chem, Chicago, IL, USA). Quantitative insulin sensitivity check index is equal to 1/(log[glucose] þ log[insulin]), which predicts insulin sensitivity with lower values representing more insulin resistance. 51 Serum aldosterone measurement Serum aldosterone was evaluated by an enzyme immunoassay kit (Cayman Chemical, Ann Arbor, MI, USA).
Determination of K
þ , Na þ , and Mg þ þ in soleus muscle Soleus muscle was analyzed for K þ , Na þ , and Mg þ þ as described previously. 52 Muscle tissue was electronically homogenized in 5% TCA and centrifuged for 10 min at 1000 g. The supernatant was diluted 1/10 with 15 mM Li 2 CO 3 for Na þ , K þ , and with 0.5% Li 2 O 3 for Mg þ þ measurements. All diluted samples were analyzed by an atomic absorption spectrophotometer. The emission wavelength of the sample and standard were read against blank at 766.5 nm for K þ , 589.0 nm for Na þ , and 285.2 nm wavelengths for Mg þ þ . The protein concentration in the supernatants was measured using the protein kit. Mg þ þ , K þ , and Na þ contents of the muscles were calculated and expressed as mmol per g wet tissue weight and mmol per mg protein.
Renal histologic studies Methyl Carnoys-fixed tissue (3-mm sections) was used for staining with periodic acid-Schiff reagent, and hematoxylin-eosin. The glomerular area and percentage of mesangial area per glomerulus of 20 mid-cross section glomeruli for each rat were evaluated by an Axioplan 2 imaging microscope (Carl Zeiss, Munich, Germany) and Zeiss AutoMeasure software (Axiovision 4.1). The severity of glomerular and tubulointerstitial injuries were determined blinded and included glomerular sclerosis, mesangial matrix expansion, glomerular ischemia, tubular cell vacuolization, tubular cell hypertrophy and hyperplasia, tubular dilatation and cast formation, tubular atrophy, interstitial cell infiltration, and fibrosis. For each slide, at least 15-20 fields were graded for the extent of injury and the mean score per biopsy was determined separately for the cortex and outer medulla on a scale from 0-5, with grade 0 ¼ no injury, 1 ¼ p10%, 2 ¼ 10-25%, 3 ¼ 25-50%, 4 ¼ 50-75%, and grade 5 ¼ 75-100% of the area determined.
Immunohistochemistry and quantification of staining An indirect immunoperoxidase method was used to identify the following antigens: osteopontin, a sensitive marker of tubulointerstitial injury, 17 with a goat polyclonal antibody (OP199, gift of C Giachelli, University of Washington, Seattle, WA, USA); macrophages with ED-1, a mouse monoclonal IgG 1 (BD Pharmingen, San Diego, CA, USA); and proliferating cells with mouse monoclonal IgG antibody to PCNA (Sigma-Aldrich, St Louis, MO, USA).
To quantify the positive expression of osteopontin by injured tubules, an Axioplan 2 imaging microscope and Zeiss AutoMeasure software were used to determine the percent area occupied by osteopontin-positive tubules at the cortex, and OSOM and ISOM where 20 fields (1100 Â 1400 mm) of each area were measured at Â 200 magnification. The mean percent area was calculated for each biopsy. The number of macrophages (ED-1-positive cells per mm 2 ) and positive PCNA cells per mm 2 in the entire cortex and medulla were counted at Â 200 magnification and the average numbers were calculated for each biopsy.
Renal 8-isoprostaglandin F 2 alpha, intracellular reduced glutathione, and NO measurements Measurements of renal oxidative stress and renal NO content were determined. Briefly, the cortex and medulla were homogenized separately at a weight/volume ratio of 1:6 with phosphate-buffered saline and sonicated. 8-iso prostaglandin F2 alpha in homogenates was measured by enzyme-linked immunosorbent assay (Cayman Chemical) and expressed in ng per g wet tissue weight. To assess intracellular-reduced glutathione and NO, the homogenate was centrifuged at a high speed of 100 000 g. Supernatant was ultrafiltrated using 10 000 Da filters. Intracellular-reduced glutathione was measured as reported previously 53 and expressed in mmol per g protein. Total NO was measured with the colorimetric assay kit (Cayman Chemical), which measures total nitrate and nitrite concentrations (NO reaction products) and is expressed in mmol per g protein. The tissue protein content of the supernatant was determined by a BCA protein assay kit (Pierce, Rockford, IL, USA).
Determination of vasorelaxation of aortic arch (AA) segments Vasorelaxation of AA rings was performed as described previously. 50 Briefly, the AA segments (1-1.5 mm diameter Â 3-4 mm length) were isolated from each group of rats and suspended in individual organ chambers (Radnoti Four-Unit Tissue Bath System). After 1 h equilibration of resting force of 1.5 g, the vascular smooth muscle cell or endothelium integrity of this AA segment was confirmed by monitoring U-46619 (a thromboxane A 2 mimetic, Sigma)-mediated AA contraction or acetylcholine-mediated vasodilatation, respectively. Stable contraction was induced by 0.5 mM U-46619 for 10 min before acetylcholine (1 mM) was added to assess the endotheliumdependent vasorelaxation response to agonist stimulating NO production. The vascular tensions were continuously monitored with an isometric force transducer (Harvard Apparatus, Holliston, MA, USA). To standardize the data, a U-46619-induced stable increase in vascular tone was set as 100%.
Measurement of serum and urinary NO Serum and urine NO were measured as markers of NO bioavailability, 54 and endothelial dysfunction. 55 Serum NO was determined using the Sievers Nitric Oxide Analyzer (NOA280i; ozonechemiluminescence technology) as described previously. 56 Urinary NO was evaluated by using the nitrate/nitrite colorimetric assay kit (Cayman Chemical).
Statistical analysis
All data are shown as mean7s.d. One-way analysis of variance (SPSS 14.0) was used to determine the significance between the mean of multiple groups. The paired and unpaired Student's t-test was used to compare the continuous variables of the specific two groups. Pearson's Correlation was used to address potential associations. Statistical significance was defined as Po0.05.
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